Media

Press Releases

CardioVax Announces Name Change to Abcentra

January 30, 2019

CardioVax, a privately held, clinical-stage biopharmaceutical company developing novel antibody therapeutics for inflammatory diseases, announced today that it has changed its name to Abcentra.